American Kidney Fund Launches Comprehensive New Kidney Disease Education Portal
May 16, 2018 11:30 ET | American Kidney Fund
ROCKVILLE, Md., May 16, 2018 (GLOBE NEWSWIRE) -- The American Kidney Fund (AFK) today unveiled CKD Central, a new free online education portal offering comprehensive information and resources on...
DiaMedica-Logo.png
DiaMedica Announces Positive Results From FDA Meeting on Planned Clinical Trial in Patients with Chronic Kidney Disease
May 03, 2018 08:30 ET | DiaMedica Therapeutics Inc.
DiaMedica has received final minutes from Type B meeting with the US FDADiaMedica preparing to submit an IND to initiate DM199 clinical study in patients with chronic kidney disease in the US ...
Endonovo Therapeutics Highlights Feasibility Study Results of Its Electroceutical Therapy in Reducing Proteinuria in Chronic Kidney Disease Patients
May 01, 2018 07:35 ET | Endonovo Therapeutics, Inc.
Company to Conduct Larger Clinical Study to Evaluate Its Electroceutical™ Therapy in Chronic Kidney Disease LOS ANGELES, CA, May 01, 2018 (GLOBE NEWSWIRE) -- Endonovo Therapeutics,...
DiaMedica-Logo.png
DiaMedica Therapeutics Announces Appointment of Scott Kellen as Chief Financial Officer
April 05, 2018 07:15 ET | DiaMedica Therapeutics Inc.
MINNEAPOLIS, April 05, 2018 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (the “Company”) (TSX-V:DMA) (OTCQB:DMCAF) is pleased to announce the appointment of Mr. Scott Kellen as Chief Financial...
DiaMedica-Logo.png
DiaMedica Therapeutics Announces Final Closing of Private Placement
March 29, 2018 18:08 ET | DiaMedica Therapeutics Inc.
MINNEAPOLIS, March 29, 2018 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (the “Company” and “DiaMedica”) (TSX-V:DMA) (OTCQB:DMCAF) is pleased to announce the successful completion of the second...
DiaMedica-Logo.png
DiaMedica Therapeutics Announces Closing of Private Placement
March 20, 2018 17:40 ET | DiaMedica Therapeutics Inc.
MINNEAPOLIS, March 20, 2018 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (the “Company”) (TSX-V:DMA) (OTCQB:DMCAF) is pleased to announce the successful completion of the first closing of a...
DiaMedica-Logo.png
DiaMedica Announces First Enrollment in its PHASE 2 “REMEDY” TRIAL for Acute Ischemic Stroke
February 22, 2018 07:00 ET | DiaMedica Therapeutics Inc.
DM199 may offer an effective and safe treatment with a significantly longer treatment window (24 hours) compared to the current standard of careREMEDY trial lead by prominent neurologist Dr. Bruce...
DiaMedica-Logo.png
DiaMedica to Present at the 14th Annual Noble Investor Conference
January 29, 2018 08:45 ET | DiaMedica Therapeutics Inc.
MINNEAPOLIS, Jan. 29, 2018 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (TSXV:DMA) (OTCQB:DMCAF), today announced that Mr. Rick Pauls, its President and CEO, will present at Noble Capital...
MULTI_LOGO_SWRPT.png
Streetwise Reports Examines Analyst’s View of ‘One of the Most Undervalued Biotech Companies in Canada’
December 07, 2017 08:45 ET | Streetwise Reports Llc
SAN FRANCISCO, Dec. 07, 2017 (GLOBE NEWSWIRE) -- David Kideckel, an analyst with Beacon Securities Ltd., explained the investment thesis for this clinical-stage life sciences firm. Included in this...
Satellite Healthcare to Present at American Society of Nephrology Annual Kidney Week Conference
October 31, 2017 09:03 ET | Satellite Healthcare
SAN JOSE, Calif., Oct. 31, 2017 (GLOBE NEWSWIRE) -- Satellite Healthcare, a leading not-for-profit dialysis provider, today announced it will present three posters and host a NephTalk lounge for...